BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,253,000 | +23.1% | 94,287 | +18.6% | 0.02% | +23.5% |
| Q2 2022 | $11,581,000 | +56.4% | 79,483 | +27.2% | 0.02% | +70.0% |
| Q1 2022 | $7,407,000 | -15.8% | 62,468 | -2.1% | 0.01% | -9.1% |
| Q4 2021 | $8,794,000 | -1.3% | 63,812 | -0.5% | 0.01% | -8.3% |
| Q3 2021 | $8,912,000 | +48.7% | 64,159 | +3.9% | 0.01% | +50.0% |
| Q2 2021 | $5,994,000 | +69.0% | 61,738 | +19.0% | 0.01% | +60.0% |
| Q1 2021 | $3,546,000 | -29.6% | 51,877 | -11.7% | 0.01% | -28.6% |
| Q4 2020 | $5,037,000 | +36.9% | 58,767 | +3.9% | 0.01% | +16.7% |
| Q3 2020 | $3,678,000 | -28.1% | 56,578 | -19.1% | 0.01% | -33.3% |
| Q2 2020 | $5,113,000 | +169.5% | 69,942 | +25.5% | 0.01% | +125.0% |
| Q1 2020 | $1,897,000 | -32.0% | 55,735 | +8.7% | 0.00% | -20.0% |
| Q4 2019 | $2,791,000 | +39.3% | 51,268 | +6.7% | 0.01% | +25.0% |
| Q3 2019 | $2,004,000 | +6.4% | 48,039 | +11.7% | 0.00% | 0.0% |
| Q2 2019 | $1,884,000 | -7.6% | 43,017 | +8.5% | 0.00% | 0.0% |
| Q1 2019 | $2,040,000 | +50.1% | 39,640 | +7.9% | 0.00% | +33.3% |
| Q4 2018 | $1,359,000 | +49.8% | 36,745 | +52.1% | 0.00% | +50.0% |
| Q3 2018 | $907,000 | -10.0% | 24,158 | -5.3% | 0.00% | 0.0% |
| Q2 2018 | $1,008,000 | +40.0% | 25,513 | -8.7% | 0.00% | 0.0% |
| Q1 2018 | $720,000 | +203.8% | 27,933 | +218.4% | 0.00% | – |
| Q4 2017 | $237,000 | -40.0% | 8,773 | -16.9% | 0.00% | -100.0% |
| Q3 2017 | $395,000 | +53.7% | 10,560 | +2.8% | 0.00% | 0.0% |
| Q2 2017 | $257,000 | – | 10,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |